Delivery Order 36F79721D0239-36C26124N0539
Award Date 3/21/24
Potential Completion Date 5/21/24
Potential Value $37K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92130, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order award to Travere Therapeutics, Inc., a biopharmaceutical company, by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 21. The contract is for the supply of Travere's specialty pharmaceutical product Filspari 400mg, which is used to treat rare diseases affecting kidney and liver function. The award has a ceiling value of $7,354.26 and a period of performance through September 30, 2024. Travere Therapeutics holds a Federal Supply...
- This federal contract award is a delivery order issued by the Department of Veterans Affairs (VA) to Travere Therapeutics, Inc., a biopharmaceutical company specializing in rare disease therapies. The contract, valued at $10,888.08, is for the supply of the pharmaceutical drug FILSPARI 200 MG. The contract was awarded through the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), and is a firm fixed-price delivery order with a completion date of June 11, 2025. Travere...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm fixed price delivery order to Travere Therapeutics, Inc., a biopharmaceutical company, to provide the pharmaceutical drug FILSPARI 200 MG. The contract, valued at $11,280.64, was issued under Travere's Pharmaceuticals and Drugs GSA Schedule contract and will be used to supply VA medical facilities in support of healthcare services for veterans. The contract does not have a set-aside designation. Travere...
- Travere Therapeutics, Inc. was awarded a $11,280.58 firm fixed price delivery order from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21. The delivery order was issued under Travere's Pharmaceuticals and Drugs General Services Administration Federal Supply Schedule contract to supply FILSPARI to VA medical facilities located in San Diego, California. No set-aside designation was applied to this award. Travere Therapeutics holds several...
- The Department of Veterans Affairs Veterans Health Administration awarded a $11,283.90 delivery order against Travere Therapeutics, Inc.'s Pharmaceuticals and Drugs GSA Schedule contract (FSS-61-IB) to provide FILSPARI 200 MG. As part of VHA's mission to provide healthcare services to veterans, this contract will supply the drug from Travere Therapeutics' Bartlett, Tennessee division to VHA's Veterans Integrated Service Network 5 facilities. With a period of performance from December 13-19,...
- Travere Therapeutics, Inc. was awarded a $18,542.20 firm fixed price delivery order from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 to supply Thioproin pharmaceutical products. The delivery order was issued under Travere's Pharmaceuticals and Drugs GSA Schedule contract (FSS-61-IB) for products to be delivered to the VA medical facility located in San Diego, California by June 2024. No set-aside designation was applied to this...
- This federal contract award is for the delivery of Thiola 100 mg, a medication produced by Travere Therapeutics, Inc., a biopharmaceutical company specializing in rare disease therapies. The contract, valued at $11,125.32, was awarded by the Veterans Integrated Service Network 5 (VISN 5) of the Department of Veterans Affairs (VA) on July 25, 2024. It is a firm fixed-price delivery order contract, with a completion date of July 26, 2024. The contract is placed under Travere Therapeutics'...
- This federal contract award to Travere Therapeutics, Inc., a biopharmaceutical company, is for the supply of Thiola 100 mg, a pharmaceutical product used to treat rare medical conditions. The contract, awarded by the Department of Veterans Affairs (VA), Veterans Integrated Service Network 5, is a firm fixed-price delivery order with a ceiling value of $32,838.56 and a period of performance through February 14, 2025. The contract is issued under the Pharmaceuticals and Drugs Federal Supply...
- The U.S. Department of Veterans Affairs (VA) has awarded a firm fixed price delivery order contract to Travere Therapeutics, Inc., a biopharmaceutical company that specializes in rare disease therapies. The contract, valued at $11,125.32, is for the supply of the pharmaceutical drug Thiola 100 mg. This delivery order is placed against Travere Therapeutics' Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract with the VA. Travere Therapeutics also holds a $25 million Blanket...
- The Department of Veterans Affairs (VA) has awarded Travere Therapeutics, Inc. a firm fixed price delivery order to provide THIOLA 100 MG, a pharmaceutical product used to treat rare diseases affecting kidney and liver function. This award is issued against Travere's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract with the VA, which serves as the primary vehicle for these types of orders. The delivery order has a potential value of $11,125.32 and a completion date of...